Please ensure Javascript is enabled for purposes of website accessibility
Specialty Cancer Care Hero Image

Grand Valley Oncology

Community Hospital’s Grand Valley Oncology is committed to improving our patients and their families’ quality of life right here on the Western Slope. We understand that access to care, comfort and compassion is important in treating cancer. In recognizing this we offer a patient-centered approach that treats the whole patient and not just the disease. We put patients first.

Clinical Trials

Clinical Trials Mission Statement

Service. Excellence. Partnerships. Integrity. Attitude.

Our mission is to provide the highest quality health care possible in a safe and comfortable environment. Clinical trials offer patients additional options for various types of cancer outside of standard treatment options. Clinical trials can help support new and innovative methods of cancer treatment options for generations to come. The National Comprehensive Cancer Network (NCCN) supports the use of clinical trials and strongly encourages participation in clinical trials for optimized management of cancer care. We continue to expand the number of clinical trials offered at Community Hospital's Grand Valley Oncology. We are working diligently to ensure patients can receive the best possible cancer care right here at home and we are proud to be the premier cancer center on the Western Slope.

What are clinical trials?

Clinical trials are research studies that test a medical, surgical or behavioral intervention in order to answer one or more questions. There are many different types of clinical trials/research studies, including but not limited to:

  • Evaluating new drugs.
  • Evaluating new ways to give already approved drugs or new combinations of drugs.
  • Evaluating new combinations of treatments such as surgery or radiation.
  • New cancer prevention methods (e.g. nutrition, exercise, etc.).
  • New methods to diagnose cancer (e.g. screening, diagnostic tests, etc.).
  • Ways to make life better for cancer patients (e.g. symptom management, counseling, etc.).
Medical Oncology Waiting Room

Participation in a clinical trial is 100% voluntary. This means you can withdraw from the study at any time if you or your medical team decide the clinical trial is no longer the best option for you.

Clinical Trial Phases

Clinical Trials are tested in a series of phases that must be followed carefully in order for a new treatment to be approved for commercial use. New testing of a treatment will begin with small populations of volunteers to determine safety and dosing parameters before moving into larger patient populations to establish the treatment as a working alternative to other commercially available treatments.

What are the benefits and risks of participation?

As with any treatment option, a clinical trial has possible benefits and drawbacks. Please discuss the following with your provider:

Possible Benefits

  • Clinical trials offer high-quality cancer care. If you are in a randomized study and do not receive the new treatment being tested, you will receive the best-known standard treatment. This may be as good as, or better than, the new approach.
  • If a new treatment is proven to work and you are receiving it, you may be among the first to benefit.
  • You have the chance to help others and improve cancer treatment.

Possible Drawbacks

  • New treatments under study are not always better than, or even as good as, standard care.
  • New treatments may have side effects that doctors do not expect or that are worse than those of standard treatment.
  • Even if a new treatment has benefits, it may not work for you. Even standard treatments, proven effective for many people, do not help everyone.
  • Health insurance and managed care providers may not cover all patient care costs in a study.

Other Resources

For more information about Clinical Research and cancer diagnoses you can access the following sites:

Hhs.gov - About Research Participation 

Cancer.gov - Clinical Trials 

Nccn.org - Cancers 

ClinicalTrials.gov - Clinical Trials Search 

Huntsman Cancer Institute - Clinical Trials 

trials

How do I participate in clinical trials?

Each clinical trial has patients with a specific type and stage of cancer. Participating in a clinical trial is your decision, however your doctor must first determine if you meet the requirements for the study you are interested in.

In general, you must meet these requirements:

  • The type and extent of your cancer has the same characteristics as the cancer being studied.
  • A doctor has reviewed your general health and it meets study requirements.
  • We have answered all of your questions about clinical trials.
  • You understand the possible benefits and risks of participating.
  • You agree to participate and you have signed and submitted your informed consent form.

For more information on the clinical trials at Community Hospital’s Grand Valley Oncology, please call (970) 644-4460.

Available Clinical Trials at Grand Valley Oncology

Click/tap the Trial I.D. for more information.

Breast
Trial Name
Trial I.D.
Trial Description
Trial Name
A011801
Trial I.D.
NCT04457596
Trial Description
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Trial Name
Opera 01
Trial I.D.
NCT06016738
Trial Description
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Leukemia
Trial Name
Trial I.D.
Trial Description
Trial Name
S1925
Trial I.D.
NCT04269902
Trial Description
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Trial Name
TAILOR
Trial I.D.
NCT05963074
Trial Description
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Solid Tumors – Multiple Disease Types
Trial Name
Trial I.D.
Trial Description
Trial Name
SGN DV-004
Trial I.D.
NCT06157892
Trial Description
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors
Trial Name
SGN DV-005
Trial I.D.
NCT06003231
Trial Description
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Trial Name
TNG462-C101
Trial I.D.
NCT05732831
Trial Description
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Other - Treatment Side Effects
Trial Name
Trial I.D.
Trial Description
Trial Name
S2010
Trial I.D.
NCT05568472
Trial Description
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Other - Quality of Life, BioMarkers, Supportive Care
Trial Name
Trial I.D.
Trial Description
Trial Name
S2013
Trial I.D.
NCT04871542
Trial Description
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Trial Name
A151804
Trial I.D.
NCT04242095
Trial Description
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Sponsors: We are currently interested in adding clinical trials to our portfolio for the following disease indications: genitourinary, gastrointestinal, gynecologic, head/neck, lung and melanoma. Please send trial surveys and information to gvoclinicaltrials@gjhosp.org .

In addition to the above trials open at Grand Valley Oncology, we also have access to several clinical trials through our research partners. Please contact us to see if we have a trial for you! 

Conflict of Interest

In accordance with Federal regulations and institutional policy, researchers at Colorado West Healthcare System and Grand Valley Oncology are required to disclose Significant Financial Interests (SFIs). Additionally, Colorado West Healthcare System and Grand Valley Oncology are required to post our institutional policy related to Financial Conflict of Interest (FCOI) for researchers. The policy is available here.

Members of the public can request and obtain the following information concerning any SFIs held be senior/key personnel for a Public Health Service funded research project where the SFI is determined to be a Financial Conflict of Interest, as defined by our policy:

  • The researcher's name
  • The researcher's title and role with respect to the research project
  • The name of the entity in which the significant financial interest is held
  • Nature of the Significant Financial Interest

Approximate dollar value (by dollar range) of the significant financial interest or statement that the interest is one whose value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

To obtain this information, please email gvoclinicaltrials@gjhosp.org. We require the name of the researcher or a description of the records of interest in order to access the information. Please include the address to which the information shall be sent. Once the request is received, a response will be provided within five business days.

Information for Sponsors

Our current FWA status can be verified by entering FWA "00024869" (or Colorado West Healthcare System) here . We have created a Site Information Profile Document to assist sponsors in assessing whether or not we may be a good fit for a potential study. Please request a copy by emailing our clinical trials team.

Our research team meets every Tuesday to review potential research studies. Please email your introduction letter and/or synopsis to gvoclinicaltrials@gjhosp.org with an attention to the research director.

Student Internship Opportunities

Grand Valley Oncology offers student internship opportunities. Please contact our clinical trials team to learn more about available internships.

Badges Clinical Trials